Clinical Trials
2 trialsNCT05907759 2026-06-02
Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT00982449 2018-09-17
124I-FIAU Imaging in EBV and KSHV Associated Cancers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed